ENO1 and cancer: Enolase (ENO-1), which converts 2-phosphoglycerate (2PG) to phosphoenol pyruvate (PEP), is emerging as a promising target for cancer therapy, partially owing to its diverse functions apart from being a major enzyme in glycolysis [89,90,91].